Clinical Trial Update: Fludeoxyglucose (FDG) F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating FDG PET, CT, and Ferumoxtran-10 MRI before chemotherapy and radiation to detect lymph node metastasis in locally advanced ce…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Endometrial Cancer

Drugs mentioned

• Ferumoxtran-10 (ferumoxtran-10)
• Fludeoxyglucose F-18 (Fludeoxyglucose F-18)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2015-12-14